Literature DB >> 12603799

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

E A Edwards1, M I Asher, C A Byrnes.   

Abstract

OBJECTIVE: Despite its decline in developed countries, bronchiectasis appeared to be a common diagnosis in Auckland, New Zealand children. The aims of this study were: to document the number of children in Auckland with bronchiectasis, their severity, clinical characteristics and possible aetiologies; to assess whether there was a relationship between ethnicity and poverty; and to estimate a crude bronchiectasis prevalence rate for New Zealand.
METHODS: A retrospective review of the case histories of all children attending a tertiary children's hospital in Auckland with bronchiectasis diagnosed by high-resolution chest computed tomography (CT) scan, during the period 1998-2000 was undertaken. Data collected included patient demographics, number of hospitalizations pre- and post-diagnosis, lung function tests, radiology and investigations. The New Zealand deprivation 1996 index was applied to the data to obtain a measure of socio-economic status.
RESULTS: Bronchiectasis was found to be common, with an estimated prevalence of approximately one in 6000 in the Auckland paediatric population. It was disproportionately more common in the Pacific Island and Maori children. In Pacific Island children, bronchiectasis not caused by cystic fibrosis was nearly twice as common in the general population than cystic fibrosis. Socio-economic deprivation and low immunization rates may be significant contributing factors. The bronchiectasis seen was extensive. Ninety-three percent had bilateral disease and 64% had involvement of four or more lobes on chest CT scan. A wide range of comorbidities and underlying aetiologies were evident.
CONCLUSIONS: Paediatric bronchiectasis in Auckland, New Zealand, is common but underresourced. Only the most severe cases are being recognized, providing a significant challenge for paediatric health professionals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603799     DOI: 10.1046/j.1440-1754.2003.00101.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  21 in total

1.  Lung resections in children for congenital and acquired lesions.

Authors:  Subhasis Roy Choudhury; Rajiv Chadha; Atul Mishra; Virendra Kumar; Varinder Singh; Nand Kishore Dubey
Journal:  Pediatr Surg Int       Date:  2007-09       Impact factor: 1.827

2.  New Zealand national incidence of bronchiectasis "too high" for a developed country.

Authors:  J Twiss; R Metcalfe; E Edwards; C Byrnes
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

3.  Outcomes in children treated for persistent bacterial bronchitis.

Authors:  Catherine Byrnes; Elizabeth Edwards
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

Review 4.  A review of non-cystic fibrosis pediatric bronchiectasis.

Authors:  Eric J Boren; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

5.  Association between Smoking Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study.

Authors:  Bumhee Yang; Kyungdo Han; Bongseong Kim; Hyung Koo Kang; Jung Soo Kim; Eung-Gook Kim; Hayoung Choi; Hyun Lee
Journal:  J Pers Med       Date:  2022-04-26

6.  Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Authors:  Gregory J Redding; Rosalyn J Singleton; Patricia C Valery; Hayley Williams; Keith Grimwood; Peter S Morris; Paul J Torzillo; Gabrielle B McCallum; Lori Chikoyak; Robert C Holman; Anne B Chang
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

7.  Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Authors:  K M Hare; K Grimwood; A B Chang; M D Chatfield; P C Valery; A J Leach; H C Smith-Vaughan; P S Morris; C A Byrnes; P J Torzillo; A C Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

8.  Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.

Authors:  J Twiss; A W Stewart; C A Byrnes
Journal:  Thorax       Date:  2006-02-07       Impact factor: 9.139

Review 9.  Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.

Authors:  Xia-Yi Miao; Xiao-Bin Ji; Hai-Wen Lu; Jia-Wei Yang; Jin-Fu Xu
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

Review 10.  Inhaled corticosteroids for bronchiectasis.

Authors:  Nitin Kapur; Helen L Petsky; Scott Bell; John Kolbe; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2018-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.